Headline

Nigeria Becomes First Country To Introduce New 5-in-1 Vaccine Against Meningitis – WHO

Published

3 weeks ago

April 13, 2024

Editor

Nigeria has become the first country in the world to roll out a new vaccine – Men5CV – recommended by the World Health Organization (WHO), to protect people against meningitis.

The World Health body, in a statement on Friday, said that the vaccine would protect people against five strains of Meningococcus bacteria and described Nigeria’s feat as historic.

It said that health workers would begin an immunisation campaign aimed at reaching one million people.

The statement said that the vaccine and emergency vaccination activities are funded by Gavi, the Vaccine Alliance, which funds the global meningitis vaccine stockpile and supports lower-income countries with routine vaccination against meningitis.

According to the WHO, Nigeria is one of the 26 meningitis hyper-endemic countries in Africa, situated in the area known as the African Meningitis Belt.

It noted that in 2023, there was a 50 per cent jump in annual meningitis cases reported across Africa.

“In Nigeria, an outbreak of Neisseria meningitidis (meningococcus) serogroup C outbreak, led to 1,742 suspected meningitis cases, including 101 confirmed cases and 153 deaths in seven of the 36 Nigerian states between October 2023 and March 2024.

“The states are Adamawa, Bauchi, Gombe, Jigawa, Katsina, Yobe, and Zamfara.

“To quell the deadly outbreak, a vaccination campaign was undertaken on March 25–28, 2024, to initially reach more than one million people aged 1-29 years,” it said.

The statement noted that meningitis is a serious infection that leads to the inflammation of the membranes (meninges) that surround and protect the brain and spinal cord.

“There are multiple causes of meningitis, including viral, bacterial, fungal, and parasitic pathogens.

“Symptoms often include headache, fever, and stiff neck. Bacterial meningitis is the most serious and can also result in septicaemia (blood poisoning). It can seriously disable or kill within 24 hours,” the statement added.

It quoted Dr Tedros Ghebreyesus, WHO Director-General, as saying that meningitis was an old and deadly foe, adding that the new vaccine holds the potential to change the trajectory of the disease, preventing future outbreaks and saving many lives.

“Nigeria’s rollout brings us one step closer to our goal of eliminating meningitis by 2030,” Ghebreyesus said.

He said that the revolutionary new vaccine offers a powerful shield against the five major strains of the meningococcal bacteria – A, C, W, Y, and X – in a single shot.

All five strains cause meningitis and blood poisoning.

According to him, this provides broader protection than the current vaccine used in much of Africa, which is only effective against the A strain.

He said that the new vaccine has the potential to significantly reduce meningitis cases and advance progress in defeating meningitis.

“This is especially important for countries like Nigeria, where multiple serogroups are prevalent.

“The new vaccine uses the same technology as the meningitis A conjugate vaccine (MenAfriVac®), which wiped out meningococcal A epidemics in Nigeria,” the WHO boss said.

The statement quoted Prof. Muhammad Pate, Nigeria’s Minister of Health and Social Welfare, as saying that Northern Nigeria, particularly the states of Jigawa, Bauchi, and Yobe, were badly hit by the deadly outbreak of meningitis.

“This vaccine provides health workers with a new tool to both stop this outbreak and also put the country on a path to elimination,” Pate said.

According to him, Nigeria has done a lot of work preparing health workers and the health system for the rollout of the new vaccine.

“We got invaluable support from our populations in spite of the fasting period, and from our community leaders, especially the Emir of Gumel in Jigawa, who personally launched the vaccination campaign in the state.

“We’ll be monitoring progress closely and hopefully expand the immunisation in the coming months and years to accelerate progress,” he said.

The minister said that the new multivalent conjugate vaccine took 13 years of effort and was based on a partnership between PATH and the Serum Institute of India.

“Financing from the UK government’s Foreign, Commonwealth, and Development Office was critical to its development,” he said.

Pate said that in July 2023, WHO prequalified the new Men5CV vaccine (which has brand name MenFive®), and in October 2023, it issued an official recommendation to countries to introduce the new vaccine.

According to him, Gavi allocated resources for the Men5CV rollout in December 2023, which are currently available for outbreak response through the emergency stockpile managed by the International Coordinating Group (ICG) on vaccine provision.

He added that the rollout, through mass preventive campaigns, was expected to start in 2025 across countries of the Meningitis Belt.

Mr Andrew Mitchell, UK Minister for Development and Africa, was also quoted as saying that the rollout of one million vaccines in northern Nigeria would help save lives, prevent long-term illness, and boost the goal of defeating meningitis globally by 2030.

“This is exactly the kind of scientific innovation supported by the UK, which I hope is replicated in years to come, to help us drive further breakthroughs, including wiping out other diseases,” Mitchell said.

He said that WHO has been supporting the Nigeria Centre for Disease Control and Prevention (NCDC) in responding to the meningitis outbreak in the country.

According to him, the areas of support include disease surveillance, active case finding, sample testing, and case management.

“WHO and partners have also played a vital role in supporting Nigeria to prepare for the rollout of the new vaccine and training health workers,” he said.

Dr Nanthalile Mugala, PATH’s Chief of Africa Region, was also quoted as saying that meningococcal meningitis had tormented countries across Africa year after year.

“The introduction of MenFive® in Nigeria heralds a transformative era in the fight against meningococcal meningitis in Africa.

“Building on the legacy of previous vaccination efforts, this milestone reflects over a decade of unwavering, innovative partnerships.

“The promise of MenFive® lies not just in its immediate impact but in the countless lives it stands to protect in the years to come, moving us closer to a future free from the threat of this disease,” Mugala said.

According to her, in 2019, WHO and partners launched the global roadmap to defeating meningitis by 2030.

“The roadmap sets a comprehensive vision towards a world free of meningitis and has three goals, including the elimination of bacterial meningitis epidemics.”

Another goal is the reduction of cases of vaccine-preventable bacterial meningitis by 50 per cent and deaths by 70 per cent, as well as the reduction of disability and improvement of quality of life after meningitis, due to any cause.

Ms Aurélia Nguyen, Chief Programme Officer at Gavi, the Vaccine Alliance, was also quoted as saying that with outbreaks of infectious diseases on the rise worldwide, new innovations such as MenFive® were critical in helping the fight back.

She said that Vaccine Alliance funds the global stockpile as well as vaccine rollout in lower-income countries.

“This first shipment signals the start of Gavi support for a multivalent meningococcal conjugate vaccine (MMCV) programme which, with the required donor funding for our next five years of work, will see pentavalent meningococcal conjugate vaccines rolled out in high-risk countries.

“Thanks to vaccines, we have eliminated large and disruptive outbreaks of meningitis A in Africa, and now we have a tool to respond to other serogroups that still cause large outbreaks, resulting in long-term disability and deaths,” Nguyen said.

According to her, following Nigeria’s meningitis vaccine campaign, a major milestone on the road to defeat meningitis is the international summit on meningitis taking place in Paris in April 2024, where leaders will celebrate progress, identify challenges and assess next steps.

“It is also an opportunity for country leaders and key partners to commit, politically and financially, to accelerate progress towards eliminating meningitis as a public health problem by 2030,” she said. (NAN)
VANGUARD

Headline

PICTORIAL: C&S Church Ayo Ni O Installs New Leader

Published

12 hours ago

May 2, 2024

Editor

The Cherubim and Seraphim (S&S) Movement Church Worldwide, on Wednesday, formally installed Prophet Emmanuel Alogbo as the 6th Baba Aladura and spiritual head of the church.

Alogbo was appointed the acting spiritual head in November 2023 following the death of his predecessor, Samuel Abidoye, who died on November 12, at the age of 103.

A statement published on the official website of the church reads, “The ascension of Most Senior Special Prophet Dr. Emmanuel Abiodun Alogbo to the revered position of Spiritual Father and Chairman of the Cherubim and Seraphim Movement Church signifies a pivotal moment in the history of the church, ushering in a new era of leadership and guidance for its global congregation.”

Alogbo’s installation was reported to have been attended by important figures in the church, “including the Olori of Cherubim and Seraphim Unification, His Most Eminence Pro. Dr. S. A. Alao J.Pil., who performed the anointment, which added to the solemnity and grandeur of the occasion.”

Alao was said to have charged the new Baba Aladura to embrace his role with strength and courage.

Congregants were also said to have recognised Alogbo as an embodiment of divine wisdom, compassion, and spiritual insight.

In his pledge to the CSMC Worldwide, the new Baba Adura was quoted assaying, “I solemnly pledge to continue the good work of moving our beloved church forward, which the late Baba Aladura Prophet Samuel Adefila Abidoye started.

“It is my firm commitment to ensure that the C&S Movement Church continues to march on, spreading its message of faith and love to all corners of the globe.”

Headline

Nigerian Man Extradited From Malaysia, Convicted For $6.3m Fraud In US

Published

15 hours ago

May 2, 2024

Editor

A federal jury in New Haven, Connecticut, Wednesday, convicted an extradited Nigerian national, Okechukwu Osuji, for engaging in a business email compromise scheme out of multiple countries, including the United States.

This was revealed in a statement by the US Department of Justice on Thursday, saying that Osuji and his accomplices, John Wamuigah and Tolulope Bodunde defrauded their victims of over $6.3 million.

The jury convicted Osuji of conspiracy to commit wire fraud, wire fraud, and aggravated identity theft.

Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the Justice Department’s Criminal Division, said, “Osuji led a network of scammers in Malaysia and elsewhere in a sophisticated business email compromise scheme to defraud victims of millions of dollars.”

“Today’s conviction is another example of how the department’s collaboration with international law enforcement partners enables us to bring cybercriminals to justice in the United States.”

US Attorney Vanessa Roberts Avery for the District of Connecticut added, “While it is often difficult to identify and bring to justice cybercriminals operating overseas, today’s verdict demonstrates the expertise of the FBI and Stamford Police in uncovering this criminal network, and the shared commitment of our counterparts in Malaysia to ensure that fraudsters are held accountable in a court of law.

“We will continue to work to root out those who engage in internet fraud schemes, no matter where in the world they operate, and achieve justice for victims of these crimes.”

“The defendant perpetrated a complex international business email compromise scheme and laundered millions in stolen proceeds,” said Executive Assistant Director Timothy R. Langan Jr. of the FBI’s Criminal, Cyber, Response, and Services Branch.

“This conviction is the result of hard work and close collaboration between the FBI and our local and international partners. Together, we will work aggressively to bring to justice anyone who engages in fraud and theft against Americans, no matter where they are in the world.”

“Today’s verdict provides a bit of closure to some victims of these often financially crippling crimes,” said Special Agent in Charge Robert Fuller of the FBI New Haven Field Office.

“It also displays our international ability to bring criminal actors to justice despite the complexities of their crimes. We want to thank all of our law enforcement partners here and abroad, as well as the U.S. Attorney’s office, for their dedication to serving justice.”

Osuji who was deported by Osuji is slated to be sentenced on July 24 and faces a mandatory minimum of two years on the identity theft count and a maximum penalty of 60 years in prison on the wire fraud and conspiracy counts.

A Federal District Court judge will determine any sentence after considering the US Sentencing Guidelines and other statutory factors.

Osuji was arrested in Malaysia and extradited to the US in 2022. His alleged co-conspirator, Wamuigah, remains in Malaysia and is pending extradition proceedings, while another co-conspirator, Bodunde, pleaded guilty on February 16.

Headline

How Two Kenyan School Dropouts Made Prosthetic Arms For People With Disabilities

Published

22 hours ago

May 2, 2024

Editor

Two young Kenyan inventors have invented bio-robotic prosthetic arms from waste materials to help improve the lives of the physically challenged people in 2021.

Both David Gathu and Moses Kiuna were at the age of 29 when they designed a bio-robotic prosthetic arm in helping the people that have lost their limbs.

Recounting their ordeal before venturing into the invention, the duo said they were forced to drop out of college because of the expensive school fees but did not let the challenges steal their vision.

Gathu and Kiuna accomplished their dream to help their communities in a workshop in Kiambu county in Kikuyu, Kenya, north of the capital Nairobi.

According to Face to Face Africa, the workshop was basically a shed made out of worn-out rusted iron sheets standing next to a chicken coop.

The floor was covered with gravel, making the ground outside the shop and the interior all but indistinguishable, as brown broken glass with tape all around fits the window frame.

Brain signal bio-robotic arm
Another significant thing about the invention was being the world’s first bio-robotic arm operated by brain signals. The invention, which is controlled by brain signals, has been billed as a game-changer in the lives of disabled people in Kenya.

Gathu and Kinyua’s invention was unique and different from most prosthetic technology which is powered by a person’s muscles.

The arm works by converting brain signals into an electric current by a “NeuroNode” biopotential headset receiver. NeuroNode biopotential was originally invented to help people suffering from paralysis and speech loss.

Also, the inventors narrated that the idea to develop an electronic prosthetic came to them during the pandemic as part of their contribution towards assisting Kenya to battle the pandemic. It was initially created to help COVID-19 sanitisation efforts.

“When the virus hit our country, we decided to create a machine that could help us decontaminate surfaces. It can also be used in schools, restaurants, hospitals,” Shoppe Black quotes Kinyua as saying.

Using waste products

According to a report by Anadolu Agency, the Kenyan inventors solved two problems with their innovations, first, by using waste products to make the environment clean and safe, and helping a community of people living with disabilities.

“People throw away a lot of things that are harmful to the environment just because they don’t work. If they don’t work, it might be just one component that’s faulty but all the other components still work and can be recycled,” Gathu said.

“We’ve recycled everything that you see here. They throw it away, we pick it up and use it. This has saved us from spending a lot of money because we’re not backed up financially by anyone to come up with our innovations.”

They picked up “junk” that people threw away – things like plastic, rubber, wiring, old computer motherboards, LED lights, USB devices, switches, optical drives, heat sinks, fans, and power supply units – components that they say could be quite expensive to purchase from a shop.

Helping the community

Speaking about the physically challenged people, he said, “The main reason we came up with this is to help people in our community who have lost their limbs. We don’t want these people to feel like they can’t do anything, we want them to be dependent on themselves.”

The arm can do many more tasks. They say they are still perfecting their device, but lack of funds has been a challenge.

David Mathenge from the Association for the Physically Disabled of Kenya (APDK), a charity NGO, says: “Such inventions are the future of the science of artificial limbs. This is the science we need to ease the challenges people with disabilities face.”